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[1]. TTS systems function in many cases only when the
pathogen is intimately associated with a host cell. In this
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context, the physical interaction between the bacterium
and the host cell induces the TTS system to deliver
virulence proteins in a single step from the bacterialType III secretion systems are used by many gram-
cytosol into the cytosol of the cell. This is a remarkablenegative bacterial pathogens of animals and plants to
task when one considers that the delivery of proteins bydeliver essential virulence factors into targeted host
gram-negative bacteria into a eukaryotic cell demandscells. The identification of chemical compounds that
transport across three biological membranes. The par-block the function of these systems is the first step
ticular set of proteins delivered by different pathogens istoward developing chemical attenuation as an effec-
highly divergent, but the bacterial machinery composingtive method for the treatment of infectious disease.
the TTS systems is quite conserved. Thus, many gram-
negative bacteria that cause disease have in commonOver the past decade it has become abundantly clear
TTS systems, which can be targeted for the develop-that despite vastly different disease outcomes caused
ment of chemical compounds to block an essential viru-by pathogenic bacteria, common mechanisms exist for
lence activity and effectively disarm this group of bacte-targeting specific virulence factors to host sites. Type
rial invaders.III secretion (TTS) systems are essential for virulence
While TTS systems are required for survival of bacteriaof many gram-negative pathogens of animals including
during infection, they are dispensable for bacteria thatspecies of Bordetella, Chlamydia, Pseudomonas, Sal-
have a free-living stage in their life cycle. Thus, a com-monella, Shigella, and Yersinia [1]. In humans, these
pound that blocks TTS will not necessarily inhibit bacte-bacteria cause a variety of diseases such as whooping
rial growth. Traditionally, antibiotics are developed tocough, plague, and several forms of gastroenteritis.
interfere with an activity, such as synthesis of DNA,Moreover, several plant diseases, which have had great
RNA, peptidoglycans, or proteins, which is essential foreconomic impact, are caused by bacteria that utilize TTS
bacterial growth or survival [2]. This approach has beensystems such as Erwinia spp., Pseudomonas syringae,
Ralstonia solanacearum, and Xanthomonas campestris very productive and has changed the fate of humanity
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with penicillin, tetracycline, and numerous other com- bacterial growth and appear to be bona fide inhibitors
pounds used in medicine today. However, the emer- of the Ysc TTS system. Interestingly, each of these com-
gence of multiple antibiotic-resistant organisms has de- pounds appears to have a different target. One com-
manded that scientists focus on alternative approaches. pound is clioxanide, an O-acetyl salicylanilide that ap-
In this issue, a group of researchers led by Mikael Elofs- pears to block the Ysc TTS system by targeting an as
son at Umea˚ University in Sweden present the result of yet unknown bacterial component required for the ex-
their approach to identify compounds that specifically pression of the Ysc TTS master regulatory gene lcrF.
inhibit the function of a TTS system. This provides scien- These results indicate clioxanide may be a candidate
tists with the platform to test the revolutionary idea that compound for evaluating whether chemical attenuation
these compounds may effectively attenuate virulence can be used to treat infections caused by pathogenic
during an infection. Chemical attenuation is a departure Yersinia and other pathogens that control TTS in a simi-
from the traditional approach to the development of lar manner. The other two compounds appear to target
antibiotics because the target is not necessarily required protein export functions of the Ysc TTS system. One of
for bacterial viability. Instead, targeting TTS is likely to these two compounds belongs to a family of haloid-
limit the bacterium’s ability to subvert the host immune containing sulfonamidobenzamides. This compound
system, thereby effectively removing its armament. This did not appear to affect expression of lcrF but interfered
would allow the host to efficiently clear the infection. with protein export by the Ysc TTS. These are properties
To identify compounds that inhibit TTS, Elofsson and that may indicate this family of compounds will provide
colleagues designed a high throughput screen to exam- several prospects for future development. The other
ine more than 9000 unique compounds. The screen was compound was an acylated salicylaldehyde hydrazone,
based on the ability to rapidly and efficiently monitor the which interfered with Ysc TTS and also affected flagel-
expression of the gene yopE in the bacterium Yersinia lar-mediated motility. This result is very exciting be-
pseudotuberculosis, which is highly expressed only cause it suggests this compound inhibits the activity
when the Ysc TTS system is functional. The choice to of closely related proteins required for the function of
use Y. pseudotuberculosis as a model organism was distantly related TTS systems. Acylated salicylaldehyde
well founded because the Ysc TTS system has been hydrazones and related compounds are therefore excel-
extensively studied and can be induced to secrete pro- lent candidates to test for inhibitory effects on TTS sys-
teins in the absence of host cell contact by culturing tems of other pathogens.
the bacteria in growth medium depleted of calcium [3]. In the broader perspective, Elofsson and colleagues
Expression of yopE was monitored by fusing a copy of have provided proof of concept that identifying chemi-
the yopE promoter to luxAB, genes originating from Vib- cals that inhibit TTS systems of bacterial pathogens is
rio harveyi that encode luciferase. This provided the viable. Chemical attenuation could also be used to target
opportunity to grow Y. pseudotuberculosis under condi-
other virulence properties of pathogenic bacteria. The
tions where the Ysc TTS system was induced and to
use of chemical attenuation is a new concept that opens
monitor the effect of test compounds on yopE expres-
the door to a new horizon on the battle against infectioussion. Using an arrayed format, a library of chemical com-
diseases. Much work still needs to be completed topounds was screened, with 12 candidate TTS inhibitors
evaluate whether this approach will be generally appli-being identified.
cable to treatment of infections caused by bacteria thatTo follow up on these initial lead compounds, several
utilize TTS systems. Scientists still need to test whethersecondary screening protocols were used to evaluate
chemical attenuation will be effective once a diseasepossible targets. These screens included evaluating the
develops. However, it should not be overlooked that thiseffect of candidate compounds for effects on bacterial
is the first step in the attempt to disarm the invader.growth, expression of other genes that are involved in
Ysc TTS functions, and evaluating whether candidate
compounds affected flagellar-dependent motility. Eval-
Glenn M. Younguating motility was a particularly clever screen since
Graduate Groups of Microbiology, Food Science,biogenesis of bacterial flagella involves an independent
and Biochemistry and Molecular BiologyTTS system that is homologous to “contact-dependent”
University of California, DavisTTS systems [4]. These secondary screens reduced the
Davis, California 95616group of lead compounds to a few strong candidates.
Nine of the compounds affected bacterial growth and,
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compounds may be valuable new candidates for the
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